Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ugarte

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Expert Opinion on Pharmacotherapy|February 7, 2025
Challenges in the care of patients with systemic lupus erythematosus and lupus nephritis in Latin AmericaClaudia Elera-Fitzcarrald, Graciela S Alarcón, Manuel F Ugarte-Gil
Rheumatology (Oxford, England)|March 29, 2023
Improving access to SLE therapies in low and middle-income countriesClaudia Mendoza-Pinto, Ivet Etchegaray-Morales, Manuel F Ugarte-Gil
Clinical Rheumatology|July 14, 2016
Treat to target in systemic lupus erythematosus: a commentaryManuel F Ugarte-Gil, Paula I Burgos, Graciela S Alarcón
Expert Review of Clinical Immunology|May 5, 2017
Epidemiology of systemic lupus erythematosusGuillermo J Pons-Estel, Manuel F Ugarte-Gil, Graciela S Alarcón
Lupus|September 11, 2025
Prevalence of systemic lupus erythematosus in Peru and its association with environmental and healthcare factors: An ecological studyPaul J Tejada-Llacsa, Graciela S Alarcón, Manuel F Ugarte-Gil
Expert Opinion on Investigational Drugs|February 16, 2016
Abatacept for the treatment of systemic lupus erythematosusVictor R Pimentel-Quiroz, Manuel F Ugarte-Gil, Graciela S Alarcón
Rheumatic Diseases Clinics of North America|May 7, 2026
Global Rheumatology Registries and CohortsManuel F Ugarte-Gil, Guillermo J Pons-Estel, Graciela S Alarcón
Clinical Rheumatology|July 20, 2015
Access to an optimal treatment. Current situationManuel F Ugarte-Gil, Adriana M R Silvestre, Bernardo A Pons-Estel
Clinical Rheumatology|May 29, 2021
Rheumatology and psychiatry: allies in times of COVID-19Claudia Elera-Fitzcarrald, Jeff Huarcaya-Victoria, Graciela S Alarcón, et al.
Rheumatology (Oxford, England)|July 1, 2024
Challenges and opportunities in access to care for systemic lupus erythematosus patients across Europe and worldwideMarta Mosca, Ian N Bruce, Jeanette Andersen, et al.
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Expert Opinion on Pharmacotherapy|February 7, 2025
Challenges in the care of patients with systemic lupus erythematosus and lupus nephritis in Latin AmericaClaudia Elera-Fitzcarrald, Graciela S Alarcón, Manuel F Ugarte-Gil
Rheumatology (Oxford, England)|March 29, 2023
Improving access to SLE therapies in low and middle-income countriesClaudia Mendoza-Pinto, Ivet Etchegaray-Morales, Manuel F Ugarte-Gil
Clinical Rheumatology|July 14, 2016
Treat to target in systemic lupus erythematosus: a commentaryManuel F Ugarte-Gil, Paula I Burgos, Graciela S Alarcón
Expert Review of Clinical Immunology|May 5, 2017
Epidemiology of systemic lupus erythematosusGuillermo J Pons-Estel, Manuel F Ugarte-Gil, Graciela S Alarcón
Lupus|September 11, 2025
Prevalence of systemic lupus erythematosus in Peru and its association with environmental and healthcare factors: An ecological studyPaul J Tejada-Llacsa, Graciela S Alarcón, Manuel F Ugarte-Gil
Expert Opinion on Investigational Drugs|February 16, 2016
Abatacept for the treatment of systemic lupus erythematosusVictor R Pimentel-Quiroz, Manuel F Ugarte-Gil, Graciela S Alarcón
Rheumatic Diseases Clinics of North America|May 7, 2026
Global Rheumatology Registries and CohortsManuel F Ugarte-Gil, Guillermo J Pons-Estel, Graciela S Alarcón
Clinical Rheumatology|July 20, 2015
Access to an optimal treatment. Current situationManuel F Ugarte-Gil, Adriana M R Silvestre, Bernardo A Pons-Estel
Clinical Rheumatology|May 29, 2021
Rheumatology and psychiatry: allies in times of COVID-19Claudia Elera-Fitzcarrald, Jeff Huarcaya-Victoria, Graciela S Alarcón, et al.
Rheumatology (Oxford, England)|July 1, 2024
Challenges and opportunities in access to care for systemic lupus erythematosus patients across Europe and worldwideMarta Mosca, Ian N Bruce, Jeanette Andersen, et al.
Pageof 14